Teva Kicks Off Trial To Revoke Bayer's Cancer Drug Patent
By Bonnie Eslinger ( May 4, 2021, 6:36 PM BST) -- Generic-drug maker Teva opened a London trial Tuesday by telling the judge that its bid to revoke three patents for Bayer's liver and kidney cancer drug had been significantly narrowed to a validity challenge against one patent....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.